Marco Taglietti, CEO, Director at SCYNEXIS, holds 272.07K shares in SCYNEXIS (Ticker: SCYX), holds ― shares in Aquestive Therapeutics (Ticker: AQST), holds 6.00K shares in Delcath Systems (Ticker: DCTH). Most recently, Marco Taglietti Bought ― shares of SCYNEXIS on Apr 28, 2022 for an estimated value of 225.00K.